Bumpaa Face Masks Achieve ISO Method Test

• Content

17 December 2020

Screenworks’ Bumpaa antiviral face masks have passed the ISO method test on the SARS-CoV-2 virus.

The test confirms that the ViralOff fabric used for these masks protect from bacterial or viral contamination. ViralOff technology effectively reduces viruses and bacteria on the product by over 99 per cent over two hours.

This is the first commercial textile treatment in the world to pass the ISO method test* on the COVID-19 virus.

Screenworks has also produced a range of antiviral gloves range, using the same technology. 

Antiviral Technology 

Duncan Gilmour, Managing Director at Screenworks, said: “We were very excited to launch our face coverings to help meet huge demand earlier in the year, and this presents another major breakthrough. We truly believe the Bumpaa face coverings can play a vital role, providing some reassurance and support during the difficult and uncertain times that lie ahead. 

“Antiviral is becoming the norm as people know that they need to do as much as possible to protect themselves and those around them. As the coronavirus continues to overshadow all our lives, more and more of us are becoming aware of the need to wash and sanitise frequently. Additional washing will have an environmental impact, so we are pleased to be behind a product which does not require frequent washing, and which can be safely reused, thus reducing disposable mask waste.

*The ISO accreditation mentioned pertains to ISO 18184:2019, SARS-CoV-2, H3N2, H1N1. ViralOff protects treated fabrics from bacterial or viral contamination but does not protect against infection or disease.

Picture: 

Article written by Ella Tansley | Published 17 December 2020

Share

Related Articles